AURA
Price
$7.77
Change
+$0.10 (+1.30%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
388.12M
53 days until earnings call
SCPH
Price
$3.27
Change
-$0.15 (-4.39%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
164.13M
60 days until earnings call
Ad is loading...

AURA vs SCPH

Header iconAURA vs SCPH Comparison
Open Charts AURA vs SCPHBanner chart's image
Aura Biosciences
Price$7.77
Change+$0.10 (+1.30%)
Volume$1.5K
Capitalization388.12M
scPharmaceuticals
Price$3.27
Change-$0.15 (-4.39%)
Volume$2.31K
Capitalization164.13M
AURA vs SCPH Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. SCPH commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and SCPH is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (AURA: $7.67 vs. SCPH: $3.42)
Brand notoriety: AURA and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 60% vs. SCPH: 34%
Market capitalization -- AURA: $388.12M vs. SCPH: $164.13M
AURA [@Biotechnology] is valued at $388.12M. SCPH’s [@Biotechnology] market capitalization is $164.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while SCPH’s TA Score has 2 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 4 bearish.
  • SCPH’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, AURA is a better buy in the short-term than SCPH.

Price Growth

AURA (@Biotechnology) experienced а -2.91% price change this week, while SCPH (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

AURA is expected to report earnings on May 08, 2025.

SCPH is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($388M) has a higher market cap than SCPH($164M). SCPH YTD gains are higher at: -3.390 vs. AURA (-6.691). SCPH has higher annual earnings (EBITDA): -71.31M vs. AURA (-91.84M). AURA has more cash in the bank: 174M vs. SCPH (91.5M). AURA has less debt than SCPH: AURA (19.1M) vs SCPH (52.5M). SCPH has higher revenues than AURA: SCPH (30.3M) vs AURA (0).
AURASCPHAURA / SCPH
Capitalization388M164M237%
EBITDA-91.84M-71.31M129%
Gain YTD-6.691-3.390197%
P/E RatioN/AN/A-
Revenue030.3M-
Total Cash174M91.5M190%
Total Debt19.1M52.5M36%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURASCPH
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with ABCL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
-0.78%
ABCL - AURA
54%
Loosely correlated
-0.68%
MGTX - AURA
50%
Loosely correlated
+3.85%
EDIT - AURA
49%
Loosely correlated
+1.64%
ABOS - AURA
48%
Loosely correlated
-5.85%
VRDN - AURA
47%
Loosely correlated
-1.90%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with MGTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
-2.29%
MGTX - SCPH
44%
Loosely correlated
+3.85%
PLRX - SCPH
44%
Loosely correlated
-8.16%
AURA - SCPH
43%
Loosely correlated
-0.78%
BEAM - SCPH
43%
Loosely correlated
+0.04%
XERS - SCPH
43%
Loosely correlated
-0.62%
More